Clinical Trials Logo

Thyroid Diseases clinical trials

View clinical trials related to Thyroid Diseases.

Filter by:

NCT ID: NCT05036525 Completed - Thyroid Diseases Clinical Trials

Evaluation of the Efficacy and Safety of a Hyaluronic Acid Gel in Adhesion Prevention After Open Thyroidectomy.

Start date: June 17, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to assess the safety and efficacy of HANBIO BarriGel to prevent thyroidectomy postoperative adhesions

NCT ID: NCT05025046 Recruiting - Thyroid Cancer Clinical Trials

NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules

Start date: September 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate the accuracy of Thyroscan in the differential diagnosis of benign and malignant thyroid nodules with suspecious ultrasound features

NCT ID: NCT05024929 Recruiting - Pediatric Cancer Clinical Trials

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Start date: July 16, 2021
Phase:
Study type: Observational

Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these drugs shrink DTC tumors in many cases, the impact on radioactive iodine (RAI) avidity has not been systematically studied.

NCT ID: NCT05022667 Recruiting - Neoplasms Clinical Trials

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

This study will see if the use of near infrared autofluorescence (NIRAF) detection with a 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx) is better than surgeon's detection alone. It compares risk, benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

NCT ID: NCT05016518 Completed - Clinical trials for Patients Undergoing Thyroid Surgery for Neoplasm

Comparison of Quality of Recovery (QoR)-15 Scores Between Propofol and Remimazolam Anesthesia

Start date: September 16, 2021
Phase: N/A
Study type: Interventional

Remimazolam is a ultra-short-acting benzodiazepine that is rapidly metabolized in the body by tissue esterase and not accumulates in the body for long periods of infusion. In addition, similar to other benzodiazepines, it is possible to reverse the sedation and anesthetic effects through flumazenil. It has no injection pain and infusion syndrome compared with propofol. There is no study to investigate overall postoperative functional recovery via QoR-15 in patients receiving TIVA using remimazolam. The purpose of this study is to determine whether there is any difference in the quality of postoperative recovery between propofol-based and remimazolam-based total intravenous anesthesia in female patients undergoing thyroidectomy. The QoR-15 questionnaire score, pain, nausea/vomiting, and the frequency of complications are evaluated and compared between the two groups.

NCT ID: NCT05015127 Recruiting - Clinical trials for Thyroid Ophthalmopathy

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Start date: September 22, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Primary Objective: To preliminarily evaluate the efficacy of the treatment regimen of HBM9161 680 mg administered subcutaneously weekly and sequentially every other week for 12 weeks in Chinese patients with active moderate to severe TED.

NCT ID: NCT05014698 Active, not recruiting - Clinical trials for Differentiated Thyroid Cancer

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

IDENTHY-K
Start date: February 23, 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC).

NCT ID: NCT05007093 Active, not recruiting - Clinical trials for DTC - Differentiated Thyroid Cancer

Study on the Treatment of Differentiated Thyroid Carcinoma With Anlotinib

Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of anlotinib in patients with locally advanced or metastatic differentiated thyroid cancer resistant to iodine therapy.

NCT ID: NCT05003856 Recruiting - Clinical trials for Recurrent Thyroid Gland Carcinoma

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

Start date: August 29, 2022
Phase: N/A
Study type: Interventional

This phase IV trial studies the effect of radiofrequency ablation in treating patients with benign or low risk thyroid nodule. Radiofrequency ablation uses a needle to deliver a high-frequency electric current to kill tumor cells by heating them. The goal of this research study is to learn if ultrasound guided radiofrequency ablation can provide the same treatment result as standard surgical removal of the thyroid nodule, small primary thyroid, or thyroid cancers that have come back. Researchers also want to learn if the procedure can be less invasive and perhaps provide a better recovery response than surgery.

NCT ID: NCT04991493 Recruiting - Thyroid Surgery Clinical Trials

Effect of Tramadol on Postoperative Sore Throat After General Anesthesia

Start date: September 10, 2021
Phase: Phase 4
Study type: Interventional

Post operative sore throat after general anesthesia with endotracheal intubation is a common problem causing dissatisfaction and discomfort to the patients. The investigators want to study the effect of tramadol on postoperative sore throat in general anesthesia with endotracheal intubation.